General Atlantic LLC Adagene Inc. Transaction History
General Atlantic LLC
- $2.79 Billion
- Q4 2024
A detailed history of General Atlantic LLC transactions in Adagene Inc. stock. As of the latest transaction made, General Atlantic LLC holds 3,825,952 shares of ADAG stock, worth $6.7 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
3,825,952
Previous 264,000
1349.22%
Holding current value
$6.7 Million
Previous $586,000
1199.15%
% of portfolio
0.27%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ADAG
# of Institutions
14Shares Held
13.6MCall Options Held
0Put Options Held
0-
Wu Xi App Tec Co., Ltd. Shanghai, F43.98MShares$6.97 Million46.44% of portfolio
-
Fil LTD Hamilton, D03.6MShares$6.3 Million0.01% of portfolio
-
Sc China Holding LTD N/A, K31.34MShares$2.35 Million0.11% of portfolio
-
Exome Asset Management LLC New York, NY263KShares$459,5930.4% of portfolio
-
Mill Creek Capital Advisors, LLC Conshohocken, PA200KShares$349,3170.01% of portfolio
About Adagene Inc.
- Ticker ADAG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,423,200
- Market Cap $76M
- Description
- Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...